Searched for
ILUMYA
Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional chargesSun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported...30 Oct, 2026, 03.38 PM IST- Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...02 Sep, 2026, 09.02 AM IST
- Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...01 Sep, 2026, 10.26 AM IST
- MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipelineSun Pharma's June quarter results met analyst expectations, signaling future growth. The company is expanding its specialty and innovative ...03 Aug, 2026, 06.30 AM IST
- Sun Pharma’s Ilumya expansion bid gets USFDA nod for reviewSun Pharmaceutical has received a significant approval from the USFDA. The company's innovative drug, Ilumya, is now being considered for t...16 Mar, 2026, 09.01 PM IST
- Sun Pharma launches Ilumya for psoriasis treatment in IndiaSun Pharmaceutical Industries has launched its innovative drug Ilumya in India. This medication treats moderate-to-severe plaque psoriasis....01 Dec, 2025, 07.23 PM IST
- Sun Pharma brings global psoriasis drug ILUMYA to Indian marketSun Pharmaceutical Industries has launched its innovative biologic drug, ILUMYA, in India for moderate-to-severe plaque psoriasis. This nov...01 Dec, 2025, 11.28 AM IST
- Sun Pharma arm launches plaque psoriasis treatment drug in JapanIn a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection...23 Sep, 2020, 10.40 AM IST
- Sun Pharma, Hikma ink exclusive pact for plaque psoriasis drug for MENA regionUnder the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA...15 Jun, 2020, 01.47 PM IST
- Sun Pharma posts Q2 profit of Rs 1,064 crore, meets Street estimatesThe drug maker had reported a loss of Rs 269.60 crore in the corresponding quarter last year.07 Nov, 2019, 03.16 PM IST
- Sun Pharma's Q1 nos: One-off boost likely from US suppliesCentrum Broking expects Sun Pharma's India sales to grow at 7 per cent for the quarter.12 Aug, 2019, 08.33 PM IST
- Reduce Sun Pharmaceutical Industries, target Rs 450: IIFLReduce Sun Pharmaceutical Industries at a price target of Rs 450.04 Apr, 2019, 06.16 PM IST
- Buy Sun Pharmaceutical Industries, target Rs 581: Nirmal Bang Institutional EquitiesBuy Sun Pharmaceutical Industries at a price target of Rs 581.06 Mar, 2019, 05.33 PM IST
- Decoding the impact of Ilumya, Sun Pharma's first biologic drug approved by the US FDALast year Sun Pharma signed another deal with South Korea's Samsung Biologics to get the drug manufactured on approval.12 Apr, 2018, 04.08 PM IST
- Sun Pharma climbs over 3% after USFDA drug nodThe company informed stock exchanges about the USFDA nod after market hours of Wednesday.22 Mar, 2018, 12.25 PM IST
- Tildra approval to give sentimental push to Sun PharmaThe drug which will be sold under the brand name Ilumya is expected to treat adults for moderate to severe plaque psoriasis, an autoimmune ...22 Mar, 2018, 09.24 AM IST
- Sun Pharma gets USFDA nod for plaque psoriasis drugThe FDA approval of the drug was supported by data from the pivotal phase-3 resurface clinical development program, it said.21 Mar, 2018, 11.29 PM IST
Load More
